Cellectis P/E
Quel est le P/E de Cellectis?
Le P/E de Cellectis est 0.00
Quelle est la définition de P/E?
Le ratio cours / bénéfice est le rapport entre le prix des actions d'une entreprise et le bénéfice par action de l'entreprise calculé sur les douze derniers mois.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E des entreprises dans Health Care secteur sur NASDAQ par rapport à Cellectis
Que fait Cellectis?
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
Entreprises avec p/e similaire à Cellectis
- Richland Resources International a P/E de N/A
- Safeplus International a P/E de N/A
- China Yanyuan Yuhui Natl Ed Grp a P/E de N/A
- Acusphere a P/E de N/A
- American Oriental Bioengineering a P/E de N/A
- Gourmet Provisions International a P/E de N/A
- Cellectis a P/E de 0.00
- SEL Manufacturing a P/E de 0.00
- China Zhong Qi Hldgs a P/E de 0.00
- MedSmart a P/E de 0.00
- Panbela Therapeutics a P/E de 0.00
- Epic a P/E de 0.00
- 2574 a P/E de 0.00